AURO-FINASTERIDE 1MG 1 MG
FINASTERIDE : 1 MG · DIN 02428148 · AURO PHARMA INC
Health Canada status: MARKETED
What is AURO-FINASTERIDE 1MG?
AURO-FINASTERIDE 1MG 1 MG contains FINASTERIDE : 1 MG. It is listed in the Health Canada Drug Product Database under DIN 02428148, held by AURO PHARMA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 12-Nov-2014. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02428148 |
|---|---|
| Brand name | AURO-FINASTERIDE 1MG |
| Generic / active ingredient | FINASTERIDE : 1 MG |
| Manufacturer | AURO PHARMA INC |
| Strength | 1 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | D11AX10 FINASTERIDE |
| AHFS class | 84:16.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 12-Nov-2014 |
| Original market date | 2014-11-12 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code D11AX10 FINASTERIDE. 8 of 10 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| FINASTERIDE | 1 MG | TABLET | SANIS HEALTH INC | MARKETED | DIN 02445085 |
| FINASTERIDE | 1 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02447568 |
| JAMP FINASTERIDE TABLETS | 1 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02554461 |
| MINT-FINASTERIDE | 1 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED | DIN 02537427 |
| PMS-FINASTERIDE | 1 MG | TABLET | PHARMASCIENCE INC | MARKETED | DIN 02320169 |
| PROPECIA | 1 MG | TABLET | ORGANON CANADA INC. | MARKETED | DIN 02238213 |
| SANDOZ FINASTERIDE A | 1 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02339471 |
| MYLAN-FINASTERIDE HG | 1 MG | TABLET | MYLAN PHARMACEUTICALS ULC | CANCELLED POST MARKET | DIN 02392631 |
| RIVA-FINASTERIDE | 1 MG | TABLET | LABORATOIRE RIVA INC. | APPROVED | DIN 02549204 |
Who else supplies FINASTERIDE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. FINASTERIDE appears in 305 registered pack listings across 15 markets, published on 12 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.